# Safety and Feasibility of the EyeControl Device

> **NCT02891629** · NA · COMPLETED · sponsor: **Eyefree Assisting Communication Ltd** · enrollment: 15 (actual)

## Conditions studied

- ALS (Amyotrophic Lateral Sclerosis)

## Interventions

- **DEVICE:** EyeControl device

## Key facts

- **NCT ID:** NCT02891629
- **Lead sponsor:** Eyefree Assisting Communication Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-01-28
- **Final completion:** 2017-02-28
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02891629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02891629, "Safety and Feasibility of the EyeControl Device". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02891629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*